Savior Lifetec Corporation (TPEX:4167)
Taiwan · Delayed Price · Currency is TWD 21.00
+0.25 (1.20%)
Mar 24, 2026, 1:30 PM CST
Savior Lifetec Market Cap
Savior Lifetec has a market cap or net worth of 6.44 billion as of March 24, 2026. Its market cap has decreased by -3.36% in one year.
Market Cap
6.44B
Enterprise Value
5.01B
Revenue
1.20B
Ranking
n/a
PE Ratio
12.13
Stock Price
21.00
Market Cap Chart
Since December 21, 2012, Savior Lifetec's market cap has increased from 3.75B to 6.44B, an increase of 71.77%. That is a compound annual growth rate of 4.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 23, 2026 | 6.44B | 12.77% |
| Dec 31, 2025 | 5.71B | -11.78% |
| Dec 31, 2024 | 6.47B | -9.13% |
| Dec 29, 2023 | 7.13B | -9.37% |
| Dec 30, 2022 | 7.86B | 29.94% |
| Dec 30, 2021 | 6.05B | -41.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Adimmune | 7.65B |
| Acepodia | 7.01B |
| Mycenax Biotech | 6.56B |
| AnnJi Pharmaceutical | 5.92B |
| Sinphar Pharmaceutical | 5.90B |
| Steminent Biotherapeutics | 5.79B |
| CHO Pharma | 5.43B |
| Panion & Bf Biotech | 5.32B |